Literature DB >> 22409294

Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy.

Jinzi Zhou1, Shuhong Wang, Xiaobo Xia.   

Abstract

OBJECTIVE: Inflammatory reaction has been shown to involve the progress of type 2 (non-insulin-dependent) diabetes. We, therefore, examined the effects of inflammatory cytokines and angiogenic factors in the pathogenesis of proliferative diabetic retinopathy (PDR) in type 2 diabetes. PATIENTS AND METHODS: Vitreous fluid samples were obtained by vitrectomy from 62 eyes of PDR patients with type 2 diabetes and from 20 eyes of age-matched non-diabetic patients. The concentrations of interleukin 1 beta (IL1B), IL6, IL8, IL10, chemokine (C-C motif) ligand 2 (CCL2), endothelin 1 (EDN1), vascular endothelial growth factor (VEGF), and tumor necrosis factor (TNF) in the vitreous samples were measured by enzyme-linked immunosorbent assay (ELISA).
RESULTS: The concentrations of LI1B, IL6, IL8, CCL2, EDN1, VEGF, and TNF in the vitreous samples were considerably higher in PDR patients in comparison with the controls. However, the level of IL10 in PDR patients was similar to that obtained in the controls. Analysis of the correlations of the studied factors revealed the correlation of VEGF and IL6, VEGF and EDN1, IL8 and CCL2, and EDN1 and TNF in PDR patients. In addition, a significant positive correlation was observed between vitreous TNF as well as EDN1 and serum HbA(1)c levels in PDR patients.
CONCLUSIONS: The inflammatory cytokines and angiogenic factors IL1B, IL6, IL8, CCL2, EDN1, VEGF, and TNF are increased in the vitreous of PDR patients without an increase in IL-10. These results add support to the role of inflammatory cytokines and angiogenic factors in the genesis of PDR. Understanding the implication of these cytokines may provide diagnostic tools and therapeutic targets for treatment and prevention of PDR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22409294     DOI: 10.3109/02713683.2012.661114

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  73 in total

1.  Connexin43 hemichannel block protects against the development of diabetic retinopathy signs in a mouse model of the disease.

Authors:  Odunayo O Mugisho; Colin R Green; David M Squirrell; Sarah Bould; Helen V Danesh-Meyer; Jie Zhang; Monica L Acosta; Ilva D Rupenthal
Journal:  J Mol Med (Berl)       Date:  2018-12-08       Impact factor: 4.599

2.  A novel and less invasive technique to assess cytokine profile of vitreous in patients of diabetic macular oedema.

Authors:  G Srividya; M Jain; K Mahalakshmi; S Gayathri; R Raman; N Angayarkanni
Journal:  Eye (Lond)       Date:  2018-01-05       Impact factor: 3.775

Review 3.  The role of inflammation in diabetic eye disease.

Authors:  Marina Mesquida; Faye Drawnel; Sascha Fauser
Journal:  Semin Immunopathol       Date:  2019-06-07       Impact factor: 9.623

Review 4.  Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment.

Authors:  Steven F Abcouwer; Thomas W Gardner
Journal:  Ann N Y Acad Sci       Date:  2014-03-27       Impact factor: 5.691

Review 5.  Imaging and Biomarkers in Diabetic Macular Edema and Diabetic Retinopathy.

Authors:  Changyow C Kwan; Amani A Fawzi
Journal:  Curr Diab Rep       Date:  2019-08-31       Impact factor: 4.810

Review 6.  Bone marrow-CNS connections: implications in the pathogenesis of diabetic retinopathy.

Authors:  Jane Yellowlees Douglas; Ashay D Bhatwadekar; Sergio Li Calzi; Lynn C Shaw; Debra Carnegie; Sergio Caballero; Quihong Li; Alan W Stitt; Mohan K Raizada; Maria B Grant
Journal:  Prog Retin Eye Res       Date:  2012-05-15       Impact factor: 21.198

7.  Angiogenic Factors and Cytokines in Diabetic Retinopathy.

Authors:  Steven F Abcouwer
Journal:  J Clin Cell Immunol       Date:  2013

8.  Changes in vitreous VEGF, bFGF and fibrosis in proliferative diabetic retinopathy after intravitreal bevacizumab.

Authors:  Jiu-Ke Li; Fang Wei; Xiao-Hong Jin; Yuan-Min Dai; Hu-Shan Cui; Yu-Min Li
Journal:  Int J Ophthalmol       Date:  2015-12-18       Impact factor: 1.779

9.  Proteolytic cleavage of vascular adhesion protein-1 induced by vascular endothelial growth factor in retinal capillary endothelial cells.

Authors:  Shiho Yoshida; Miyuki Murata; Kousuke Noda; Takashi Matsuda; Michiyuki Saito; Wataru Saito; Atsuhiro Kanda; Susumu Ishida
Journal:  Jpn J Ophthalmol       Date:  2018-02-01       Impact factor: 2.447

10.  The effect of intravitreal bevacizumab injection as the initial treatment for Coats' disease.

Authors:  Xiao-Xue Zheng; Yan-Rong Jiang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-07-20       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.